plozasiran

FDA Drug Profile — REDEMPLO

Drug Details

Generic Name
plozasiran
Brand Names
REDEMPLO
Application Number
NDA219947
Sponsor
Arrowhead Pharmaceuticals, Inc.
NDC Codes
1
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
PLOZASIRAN

Indications and Usage

1 INDICATIONS AND USAGE REDEMPLO is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS). REDEMPLO is an apolipoprotein C-III ( apoC-III )-directed small interfering ribonucleic acid (siRNA) indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS). ( 1 )